Detalhe da pesquisa
1.
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Blood
; 140(13): 1470-1481, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849650
2.
Urban Churches Show an Increase in Attendance, Donations, and Finances During the COVID-19 Pandemic in the USA: Evidence from the United Methodist Church.
J Relig Health
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709431
3.
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months.
Pediatr Blood Cancer
; 68(5): e28977, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629819
4.
A universal ratiometric method for Micro-RNA detection based on the ratio of electrochemical/electrochemiluminescence signal, and toehold-mediated strand displacement amplification.
Anal Chim Acta
; 1257: 341119, 2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062560
5.
Effect of food on the bioavailability of lesogaberan given as an oral solution or as modified-release capsules in healthy male volunteers.
Int J Clin Pharmacol Ther
; 50(4): 307-14, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22456303
6.
Pathway Analysis of Patients with Severe Acute Respiratory Syndrome.
Drug Res (Stuttg)
; 72(8): 466-472, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952682
7.
Loading of Coal Tar in Polymeric Nanoparticles as a Potential Therapeutic Modality for Psoriasis.
ACS Omega
; 7(8): 7333-7340, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35252723
8.
Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease.
Clin Pharmacokinet
; 58(10): 1295-1307, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972696
9.
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
Clin Drug Investig
; 39(8): 765-773, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140114
10.
A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
Clin Ther
; 29(4): 640-9, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17617287
11.
Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies.
Eur J Gastroenterol Hepatol
; 17(2): 191-7, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15674097
12.
Pharmacokinetics of esomeprazole following varying intravenous administration rates.
Basic Clin Pharmacol Toxicol
; 97(6): 351-4, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16364049
13.
Intravenous Esomeprazole 40mg is Effective for the Control of Intragastric Acid Levels Whether Given as a 3-Minute Injection or a 30-Minute Infusion.
Clin Drug Investig
; 25(8): 517-25, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17532695
14.
Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.
Clin Drug Investig
; 34(11): 763-72, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25269885
15.
Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Am J Cardiovasc Drugs
; 14(3): 217-27, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677117
16.
Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: a novel GABA(B)-receptor agonist reflux inhibitor.
Drugs R D
; 11(1): 77-83, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21410297
17.
Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects.
Drugs R D
; 10(4): 243-51, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21171670